CIBC World Keeps 'Strong Buy' on XOMA

Analyst Matthew Geller believes the announcement of a delay in a new drug filing could end up being net positive for the pharmaceutical concern

CIBC World reiterates strong buy on XOMA Ltd. (XOMA ).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.